How would you approach diagnosis of this widespread, nonpruritic rash? Lab work? Skin tests? Or will history and physical findings suffice?
Novel CBD Cream Shows Promise in Protecting Skin from UV-A Damage in First-Ever In-Human Trial
Results showed that a nanoencapsulated CBD cream reduced UV-A–induced nuclear and mitochondrial DNA damage linked to photoaging in human skin.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose
Your daily dose of the clinical news you may have missed.
Elderly Atopic Dermatitis Cases Up 85% in the US Since 1990, New Study Shows
New data also demonstrated mixed sex disparities in elderly atopic dermatitis prevalence.
FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
Dupilumab (Dupixent) is the first new targeted therapy for CSU in over a decade.
Emerging Therapies Show Potential for Hard-to-Treat Chronic Spontaneous Urticaria
New data highlight the potential of dupilumab, remibrutinib, and barzolvolimab to expand treatment options for patients with CSU unresponsive to current therapies.